In the present study, we have specifically focused on the analysis of tumor and non-tumor samples for the methylation status of SFRP2 in an independent prospective cohort study, together with its association with the clinical and pathological features of CRC patients. The gene discussed is SFRP2; the disease is colorectal carcinoma.